Funding Data Link References Status API Help
Page 1 of 1 results
Sort by: relevance publication year

RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

Journal Article published 1 Jan 2016 in Neuromuscular Diseases volume 6 issue 4 on pages 28 to 36

Authors: F. A. Khabirov, T. I. Khaibullin, E. V. Granatov, N. N. Babicheva, L. A. Aver’yanova, S. R. Shakirzyanova